The traditional focus of preclinical studies has always been on safety. And for good reason. Many […]
The FDA’s Innovative Science and Technology Approaches for New Drugs (ISTAND) Program is one of the clearest windows into […]
How NAMs are powering animal-free clinical trials.
New Approach Methodologies (NAMs) have the potential to transform global drug development in the next few […]
Scientific and regulatory sentiment has reached an inflection point. Around the world, governments are signaling a […]